Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-11

Clinical Trial Update: Use of the Combination of Sumatriptan and Naproxen in the Acute Treatment of Migraine: Real World Evidence Study

View source ↗

Summary

A real-world evidence study evaluating the combination of sumatriptan and naproxen for acute treatment of migraine; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan/Naproxen combination (sumatriptan/naproxen)

Snippet

Sponsor: IRCCS San Raffaele Roma | Conditions: Migraine | Status: NOT_YET_RECRUITING